| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 12,880 | 14,424 | 5,938 | 16,560 | | Cost of Revenue | 21,683 | 10,248 | 6,059 | 15,242 | | | Gross Profit | 3,934 | 4,176 | (121) | 1,317 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,101 | 2,333 | 2,651 | 2,057 | | Non Recurring |
-
|
-
|
-
| 1,321 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,833 | 1,843 | (2,772) | (2,061) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 75 | 56 | 88 | (179) | | Earnings Before Interest And Taxes | 1,908 | 1,899 | (2,684) | (2,240) | | Interest Expense | 334 | 331 | 206 | 322 | | Income Before Tax | 1,574 | 1,568 | (2,890) | (2,561) | | Income Tax Expense | 40 | 135 | (116) | 115 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,534 | 1,433 | (2,774) | (2,676) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (0) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,534 | 1,433 | (2,774) | (2,676) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,534 | $1,433 | ($2,774) | ($2,676) |
|
0.02% Nasdaq 
0.05 (1.69%) 
Income Statement
